1 |
Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics—2018 update: a report from the american heart association [J]. Circulation, 2018, 137(12): e67-e492.
|
2 |
Peng B, Cui LY. Treatment for acute ischemic stroke: new evidence from China [J]. Chin Med J, 2013, 126(18): 3403-3404.
|
3 |
Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke [J]. N Engl J Med, 2015, 372(11): 1019-1030.
|
4 |
Eryildiz ES, Ozdemir AO. Factors associated with early recovery after intravenous thrombolytic therapy in acute ischemic stroke [J].Noro Psikiyatr Ars, 2018, 55(1);80-83.
|
5 |
Urra X, Ariño H, Llull L,et al. The outcome of patients with mild stroke improves after treatment with systemic thrombolysis [J]. PLoS One, 2013, 8(3): e59420.
|
6 |
Zhang LB, Cheng RS, Wang DH, et al. Effect of intravenous thrombolysis of Alteplase in treatment of acute ischemic stroke [J]. J Neurol Sci, 2019, 405(Supl): 69-70.
|
7 |
Acciarresi M, Caso V, Venti M, et al. First-ever stroke and outcome in patients admitted to perugia stroke unit: predictors for death, dependency, and recurrence of stroke within the first three months [J]. Clin Exp Hypertens, 2006, 28(3-4): 287-294.
|
8 |
Powers William J, Rabinstein Alejandro A, Ackerson Teri Adeoye Opeolu M, et al. 2019年急性缺血性卒中患者早期管理指南: 针对2018年急性缺血性卒中早期管理指南的更新 [J]. 国际脑血管病杂志, 2020, 28(1): 1-43.
|
9 |
Tseng YJ, Hu RF, Lee ST, et al. Risk factors associated with outcomes of recombinant tissue plasminogen activator therapy in patients with acute ischemic stroke [J]. Int J Environ Res Public Health, 2020, 17(2): 618.
|
10 |
Deuchar GA, Kralingen J, Work LM, et al. Preclinical validation of the therapeutic potential of glasgow oxygen level dependent (GOLD) technology: a theranostic for acute stroke [J]. Transl Stroke Res, 2019, 10(5): 583-595.
|
11 |
Strbian D, Soinne L, Sairanen T, et al. Ultraearly thrombolysis in acute ischemic stroke is associated with better outcome and lower mortality [J]. Stroke, 2010, 41(4): 712-716.
|
12 |
Mehta A, Mahale R, Buddaraju K, et al. Intravenous thrombolysis for acute ischemic stroke:review of 97 patients [J]. J Neurosci Rural Pract, 2017, 8(1): 38-43.
|
13 |
安强, 高彩红. 阿替普酶静脉溶栓联合丁苯酞注射液治疗急性缺血性脑卒中的临床效果 [J/OL]. 中华脑血管病杂志(电子版), 2020, 14(3): 155-158.
|
14 |
Emberson JR, Hacke W. Impact of treatment delay, age and stroke severityon the effects of intravenous thrombolysis with altepase in acute ischemic stroke: an individual-patient-data meta-analysis [J]. Lancet, 2014, 384(9958): 1929-1935.
|
15 |
Saposnik G, Di Legge S, Webster F, et al. Predictors of major neurologic improvement after thrombolysis in acute stroke [J]. Neurology, 2005, 65(8): 1169-1174.
|
16 |
Çetiner M, Aydin HE, Güler M, et al. Predictive factors for functional outcomes after intravenous thrombolytic therapy in acute ischemic stroke [J]. Clin Appl Thromb Hemost, 2018, 24(9 suppl): 171S-177S.
|
17 |
Huang YH, Zhuo ST, Chen YF, et al. Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator [J]. Chin Med J, 2013, 126(24): 4685-4690.
|
18 |
Demchuk AM, Tanne D, Hill MD, et al. Predictors of good outcome after intravenous tPA for acute ischemic stroke [J]. Neurology, 2001, 57(3): 474-480.
|
19 |
Liu M, Pan Y, Zhou L, et al. Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke [J]. PLoS One, 2017, 12(9): e018464.
|
20 |
Willmot M, Leonardi-Bee J, Bath PMW. High blood pressure in acute stroke and subsequent outcome: a systematic review [J]. Hypertension, 2004, 43(1): 18.
|